1 EXHIBIT 1.1 THE CONFIDENTIAL PORTION OF THIS CONTRACT HAS BEEN OMITTED PURSUANT TO REGULATION 240.25B-2(B) OF THE SECURITIES EXCHANGE ACT OF 1934, AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION. RESEARCH, LICENSE, SUPPLY AND ROYALTY AGREEMENTSupply and Royalty Agreement • September 18th, 1997 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 18th, 1997 Company Industry Jurisdiction
1 EXHIBIT 1.1 THE CONFIDENTIAL PORTION OF THIS CONTRACT HAS BEEN OMITTED PURSUANT TO REGULATION 240.25B-2(B) OF THE SECURITIES EXCHANGE ACT OF 1934, AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION. RESEARCH, LICENSE, SUPPLY AND ROYALTY AGREEMENTSupply and Royalty Agreement • June 12th, 1997 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 12th, 1997 Company Industry Jurisdiction